Ovid Therapeutics (OVID)'s 30-day implied volatility (IV30) was 65.1% at the close on October 23, 2026, down from 94.2% the day before, against a 52-week range of 48.2% to 131.4%. Its 20-day historical volatility was 69.7%.
Data as of October 23, 2026.